Your browser doesn't support javascript.
loading
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.
Chen, Cheng; Li, Kesang; Jiang, Hua; Song, Fei; Gao, Huiping; Pan, Xiaorong; Shi, Bizhi; Bi, Yanyu; Wang, Huamao; Wang, Hongyang; Li, Zonghai.
Affiliation
  • Chen C; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.
  • Li K; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.
  • Jiang H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.
  • Song F; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.
  • Gao H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.
  • Pan X; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.
  • Shi B; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.
  • Bi Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.
  • Wang H; CARsgen Therapeutics, Shanghai, China.
  • Wang H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China. hywangk@vip.sina.com.
  • Li Z; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, 225 Changhai Road, Shanghai, China. hywangk@vip.sina.com.
Cancer Immunol Immunother ; 66(4): 475-489, 2017 Apr.
Article de En | MEDLINE | ID: mdl-28035433
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines de fusion recombinantes / Récepteurs aux antigènes des cellules T / Lymphocytes T / Immunothérapie adoptive / Carcinome hépatocellulaire / Vaccins anticancéreux / Tumeurs du foie Limites: Animals / Humans Langue: En Journal: Cancer Immunol Immunother Sujet du journal: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Année: 2017 Type de document: Article Pays d'affiliation: Chine Pays de publication: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines de fusion recombinantes / Récepteurs aux antigènes des cellules T / Lymphocytes T / Immunothérapie adoptive / Carcinome hépatocellulaire / Vaccins anticancéreux / Tumeurs du foie Limites: Animals / Humans Langue: En Journal: Cancer Immunol Immunother Sujet du journal: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Année: 2017 Type de document: Article Pays d'affiliation: Chine Pays de publication: Allemagne